All these results demonstrate that the LPS fragments released from MRT+MH-treated Fn are capable of activating the macrophages into M1 polarization via the TLR4/MyD88/NF-κB pathway, which results in significant secretions of various cytokines against tumor cells in vitro. The gene discussed is MYD88; the disease is neoplasm.